(Q36248945)

13 August 2017

Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer (English)

1 reference

13 August 2017

0 references

1 reference

1 reference

5

David R Gandara

1 reference

13 August 2017

8

Oliver Fiehn

1 reference

13 August 2017

3

Brian C DeFelice

1 reference

13 August 2017

Johannes F Fahrmann

1

1 reference

13 August 2017

Kyoungmi Kim

2

1 reference

13 August 2017

Sandra L Taylor

4

1 reference

13 August 2017

Ken Y Yoneda

6

1 reference

13 August 2017

David T Cooke

7

1 reference

13 August 2017

Karen Kelly

9

1 reference

13 August 2017

Suzanne Miyamoto

10

1 reference

13 August 2017

17 August 2015

1 reference

Cancer Epidemiology, Biomarkers & Prevention

13 August 2017

1 reference

13 August 2017

24

1 reference

13 August 2017

11

1 reference

13 August 2017

1716-1723

1 reference

Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Cancer metabolomics in basic science perspective.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Altered glutamine metabolism and therapeutic opportunities for lung cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

A blood-based proteomic classifier for the molecular characterization of pulmonary nodules.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

The state of molecular biomarkers for the early detection of lung cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Metabolomics in cancer: a bench-to-bedside intersection

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Differences between human plasma and serum metabolite profiles

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Clinical applications of metabolomics in oncology: a review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Quality control for plant metabolomics: reporting MSI-compliant studies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

SetupX--a public study design database for metabolomic projects

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Phases of biomarker development for early detection of cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

A jackknife and voting classifier approach to feature selection and classification.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

22 September 2018

Metabolomics of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Panel of serum biomarkers for the diagnosis of lung cancer

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Is Serum or Plasma More Appropriate for Intersubject Comparisons in Metabolomic Studies? An Assessment in Patients with Small-Cell Lung Cancer

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633344

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26282632

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1055-9965.EPI-15-0427

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

26282632

1 reference